|
Aug 1
|
Top Midday Stories: Meta Shares Rise on Earnings Beat; Toyota Shares Fall on Slowing Momentum; US Seeking Rule on Airline 'Junk Fees'; Disney, Fox, Warner Bros. Discovery Price Sports Streaming Subscription
|
|
Aug 1
|
Should You Buy AbbVie (ABBV) After Q2 Beat, Guidance Raise?
|
|
Aug 1
|
AbbVie Completes Acquisition of Cerevel Therapeutics
|
|
Jul 29
|
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 28
|
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
|
|
Jul 27
|
AbbVie Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 26
|
AbbVie's Immunology Products Continue to Deliver, Morgan Stanley Says
|
|
Jul 26
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
|
Jul 26
|
Two biotechs cut staff; AbbVie weathers biosimilar threat
|
|
Jul 26
|
AbbVie’s Q2 2024 net earnings drop to $1.37bn
|
|
Jul 26
|
Company News for Jul 26, 2024
|
|
Jul 26
|
Q2 2024 AbbVie Inc Earnings Call
|
|
Jul 26
|
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
|
|
Jul 25
|
Why AbbVie Stock Was Cruising Higher on Thursday
|
|
Jul 25
|
AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
|
|
Jul 25
|
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
|
|
Jul 25
|
AbbVie Stock Hits Record High on Demand for Non-Humira Portfolio
|
|
Jul 25
|
AbbVie Stock Rises on Strong Sales of Immunology Drugs Other Than Humira
|
|
Jul 25
|
AbbVie stock gets lift after beating Q2 earnings estimates
|